SCHEMBL4773121

SCHEMBL4773121

NCC1CCCC(CNc2cc(-c3cccnc3)nc(-c3ccccn3)n2)C1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR39 O43194 5/20 0.46
VCP P55072 2/20 0.44
HIF1A Q16665 2/20 0.43
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2A6 P11509 1/20 0.41
GBA1 P04062 1/20 0.41
SLC2A1 P11166 1/20 0.40
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
PKM P14618 1/20 0.39
TSHR P16473 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PRKCQ Q04759 1/20 0.39
PDE5A O76074 2/20 0.38
IDH1 O75874 1/20 0.38
TRPM8 Q7Z2W7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4768751 0.79 IRAK4 (0.46) GPR39VCPCYP3A4CYP2C9CYP2A6
SCHEMBL4771527 0.74 CYP3A4 (0.55) HIF1ACYP3A4CYP2C9CYP2A6SLC2A1
SCHEMBL2239929 0.74 CYP3A4 (0.65) GPR39VCPHIF1ACYP3A4CYP2C9
SCHEMBL4775842 0.74 CYP3A4 (0.60) HIF1ACYP3A4CYP2C9CYP2A6SLC2A1
SCHEMBL4878463 0.73 SYK (0.47) GPR39CYP2A6GBA1NPC1TP53
SCHEMBL4769045 0.73 HDAC1 (0.48) HIF1ACYP3A4CYP2C9CYP2A6SLC2A1
SCHEMBL4773261 0.73 SYK (0.47) GPR39CYP2A6GBA1NPC1TP53
SCHEMBL4775067 0.73 CYP3A4 (0.57) GPR39VCPHIF1ACYP3A4CYP2C9
SCHEMBL2238098 0.72 PTGDR (0.53) HIF1ACYP3A4CYP2C9CYP2A6GBA1
SCHEMBL2240945 0.72 GBA1 (0.54) HIF1ACYP3A4CYP2C9CYP2A6GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed